Peptides are here Im beginning the next phase of integrating BPC-157 and TB-500 #peptides into my regenerative podiatry protocol for patients with chronic foot pain and connective tissue injuries such as #plantarfasciosis #plantarplatetear #achillestendinopathy Combining clinical peptides with #systemicenzymes and #exosomes is becoming one of the most promising approaches in restoring tissue health, reducing inflammation, and improving long-term foot function
Heres what its reported to do: Stimulates angiogenesis (formation of new blood vessels)
Compound: Tesamorelin 16mg Sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH Molecular Formula: C 223 H 370 N 72 O 69 S Molecular Weight: 5196 g/mol PubChem CID: 44147413 CAS Number: 901758-09-6 ---------- Compound: Ipamorelin 4mg Sequence: H-Aib-His-D-2Nal-D-Phe-Lys-NH2 Molecular Formula: C 38 H 49 N 9 O 5 Molecular Weight: 711.9 g/mol PubChem CID: 9831659 ---------- Vial Size: 3ml Store at -20C (freezer) for long-term stability
Baseline b12 tests at 280 pg per milliliter, low-normal range
DiAntonio A (2019) Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy
HCA was also shown to suppress T-bet expression, which is involved in the induction of IFN-, suppression of IL-2 in TH cells, and suppression of T-bet-stimulated Th1 cell differentiation
